Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. - Wikidata - awgldk - TriplyDB

Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

http://www.wikidata.org/entity/Q37439827

about

HIV infection and older Americans: the public health perspective T-cell aging in rheumatoid arthritis Frailty, HIV infection, and mortality in an aging cohort of injection drug users The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals HIV-related mortality among adults (≥18 years) of various Hispanic or Latino subgroups – United States, 2006–2010 Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.Employing human rights frameworks to realize access to an HIV cure.DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS.A pandemic of the poor: social disadvantage and the U.S. HIV epidemic.Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting.Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol.Patient demographic and health factors associated with frequent use of emergency medical services in a midsized city.Frailty and Pre-Frailty in a Contemporary Cohort of HIV-Infected Adults Non-AIDS-Defining Malignancies in the HIV-Infected Population HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial.HIV infection, inflammation, immunosenescence, and aging.Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes.Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaques.Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, Canada Health status of HIV-infected women entering care: baseline medical findings from the women of color initiative Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.Linkage to care for HIV-infected heterosexual men in the United States Main partner factors associated with worse adherence to HAART among women in Baltimore, Maryland: a preliminary study Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and design The lifetime medical cost savings from preventing HIV in the United States.Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.Essential components of effective HIV care: a policy paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition.Influence of residential segregation on survival after AIDS diagnosis among non-Hispanic blacks.Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV Cancer screening in patients infected with HIV.Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.

P2860

Q26858824-AA34A073-EEAA-4967-8A24-A4886E8DE3C0 Q26859971-175DFBB6-1BC4-41CE-9F09-ACBCB12AB0E0 Q28485898-01FFC251-2C69-4F9F-B346-3D2A98DA8F26 Q28535156-63074395-0642-430B-B5A5-9C00E3A4A65D Q28537704-891CE572-2E97-4A25-ABBB-3522EE2BFD13 Q28610686-2FEB20B3-5F3E-42B5-86E6-D9DE4F672475 Q28730050-F9850085-AE5E-4A8B-8E8A-2458509B421A Q29248882-BD28AFC2-EA4A-4F63-8459-D340C60D8FC8 Q30248351-17A424ED-B921-49FB-A0BE-2229B26B6478 Q30252460-4AD4C89B-EB8E-48AE-BB11-265A1A0903B9 Q30381361-CCEA19A0-2DF5-4CF9-A3AC-64D6DEDB18EF Q30408029-DBC45CD0-DABF-4385-8F9E-E334A0EAE70C Q30430745-FCC615BD-BF3D-4A79-9EE9-E98C0E2D0155 Q30666487-CBAD4166-5BC0-4EB9-A76F-1F95167D2920 Q33640329-59F2D52C-4C47-4234-BD2C-E81BE22DF34B Q33640486-079036F3-B863-4A45-B689-92B9589A03C3 Q33777223-01E7614C-395B-4F82-9806-B2EE5FEE5E00 Q33813894-4B50254E-B884-43FC-90D9-EA003FDACD01 Q33859370-9E42BF4C-57E4-4ED6-B875-D4ECCF6C5A6E Q33907350-D7AEDF9E-F05B-4D4E-A44E-78298213405E Q34055648-019E169B-4B56-4070-9EB1-8298B4287001 Q34104857-E6847934-94EF-49ED-A1A0-8CB4C5E6B0A7 Q34150710-E23E0277-B2A4-4B93-B364-41F13CEA7B28 Q34455423-A854232D-4B39-42D4-86A2-798C364CECD7 Q34459345-837AE7F2-2C77-401F-B185-75C4CE989BCC Q34596417-615F3027-A4A6-4BFB-84D3-65F897DF2A10 Q34667707-3D31C6A7-EB63-46F3-93A4-0FC00DB2AF1E Q34776035-4E26509C-F5BE-4F37-AA37-AA92AE20AD4F Q34811502-8FFAA483-B180-4376-880B-21D20C6C59BF Q35003408-95E8A1E6-E9DE-421D-91C0-1C1B3ADCA763 Q35019900-5AFAF632-1B54-402E-ADB1-E97E108B1484 Q35100296-C1EC288D-31C2-4085-8BB7-3649A8CE2FE7 Q35150425-28F18300-289C-4BD7-846D-C0FF0EC055B5 Q35177401-1C4D3634-FA45-42C3-8B39-35D3BD8E070D Q35316315-6EECF4C7-B725-466D-A8FB-8D2B9C4516BC Q35488888-40641F88-99B0-4E12-9E03-BF1896F6C6F9 Q35556833-4B93A903-2D30-4A02-8E6E-8F3D743486AC Q35836811-AA46D485-2F5B-4423-840A-1DE61851FB09 Q35838509-1066815B-2EE5-4AFF-9853-D027786CE4E2 Q35875093-9B4856C1-F930-4C88-883B-F02A84882F40

P2860

Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

http://www.wikidata.org/entity/Q37439827

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Racial and sex disparities in ...... ion of antiretroviral therapy.

@en

Racial and sex disparities in ...... ion of antiretroviral therapy.

@nl

type

label

Racial and sex disparities in ...... ion of antiretroviral therapy.

@en

Racial and sex disparities in ...... ion of antiretroviral therapy.

@nl

prefLabel

Racial and sex disparities in ...... ion of antiretroviral therapy.

@en

Racial and sex disparities in ...... ion of antiretroviral therapy.

@nl

P1433

Q37439827-8DB5259C-374D-4F72-9A39-13A24CE331BE

P1476

Q37439827-3D0FEEAB-757D-4068-B341-24BC4152AECC

P2093

Q37439827-36F727FE-BA51-40C0-9A28-CE00CBEF6C76

Q37439827-888E6191-DE33-43C9-A497-107B15C0DA1D

Q37439827-AD07EE84-3EC3-4DAD-9F61-E5B1B1497050

Q37439827-C23AA749-D9EE-4BF6-B3D5-25172C6BA3A8

Q37439827-E54F8C06-3586-4188-B59E-FA001A2678EB

Q37439827-E6465E1E-004F-450C-A5A5-22C5F56301B1

Q37439827-FA9C4988-5510-4A42-9E6B-A941EFA73EB8

P2860

Q37439827-03244267-B94C-40BB-8FCE-C8FC9A04CE93

Q37439827-0642202C-F30A-438E-B630-AD06A48E9F4C

Q37439827-06F6B9BB-EEA1-47E7-8BBF-AAEE16A53382

Q37439827-0AEBC3C4-355F-4C3E-B7B5-86041E234749

Q37439827-0BED5739-4416-4E9D-946A-284FC20AB1CC

Q37439827-1157317D-9EB5-4236-8BE3-E664C3CBEAE7

Q37439827-1310EC6C-9333-43DA-89E2-484CD5B11A78

Q37439827-14B3331B-A375-4982-8067-3C49485D1204

Q37439827-19CF1A23-4C38-460A-B429-D4DBDC4B0AFF

Q37439827-26F5ECB5-0271-4D13-AA15-B0D4F82762CF

P304

Q37439827-501040C2-C051-404C-A4B0-49AD30C59D9F

P31

Q37439827-492EF41A-37DE-4364-BD5C-C71AC42EC048

P356

Q37439827-251C81DF-79C6-4064-8C40-E8B54B370ED8

P407

Q37439827-E0BA004E-1F73-4B8B-8119-063679FE2276

P433

Q37439827-93D62178-9969-418D-973B-8DF4EA627892

P478

Q37439827-083A5341-190B-4B62-8A8A-EC38C4215B51

P50

Q37439827-2889AC0C-446E-433B-9475-6A03926F1742

Q37439827-3D43B57D-8BE0-47FB-BEC4-3233DCF0667E

Q37439827-A1A8D59F-D556-47B7-8A15-370931137CD1

Q37439827-A54C4F27-B797-4BAA-87A8-71B07355C3A7

Q37439827-E66FCACD-F6EB-4567-80C8-418B040A7D79

P577

Q37439827-52638CB7-9CEC-4A85-B7F4-F59B4B016417

P5875

Q37439827-C863E752-75BA-4AD9-98E0-58C930247B45

P698

Q37439827-B1DEBD07-0D2D-4C76-BAE3-A66C10747BF1

P921

Q37439827-2E6D61A1-64FF-44E9-9810-8E59C65B01D0

Q37439827-4D00644E-75C7-4AAE-8A5D-2D60E3D43092

Q37439827-7102D161-EBA8-4BA5-AB4F-232E877CEFF9

P932

Q37439827-8784544D-B222-479F-8798-D10D3F9D9389

P356

P1433

Clinical Infectious Diseases

P1476

Racial and sex disparities in ...... tion of antiretroviral therapy

@en

P2093

Bruce R Schackman

http://www.w3.org/2001/XMLSchema#string

John J Chiosi

http://www.w3.org/2001/XMLSchema#string

Kelly A Gebo

http://www.w3.org/2001/XMLSchema#string

Perrin L Hicks

http://www.w3.org/2001/XMLSchema#string

Richard D Moore

http://www.w3.org/2001/XMLSchema#string

Sara N Sadownik

http://www.w3.org/2001/XMLSchema#string

Wendy H Aaronson

http://www.w3.org/2001/XMLSchema#string

P2860

Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.

Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.

Management of HIV infection in patients with substance use problems

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Liver disease in alcohol abusers: clinical perspective.

Factors associated with premature mortality among young injection drug users in Vancouver

Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London.

Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS.

Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

P304

1570-1578

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/644772

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Milton Weinstein

Rochelle P. Walensky

A. David Paltiel

Kenneth A Freedberg

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38026399

http://www.w3.org/2001/XMLSchema#string

P698

19845472

http://www.w3.org/2001/XMLSchema#string

P921

life expectancy

antiretroviral drug

P932

2783631

http://www.w3.org/2001/XMLSchema#string